OK SB 1030
died on adjournmentPrescription drug pricing; prohibiting certain action. Effective date.
Oklahoma · 2026 Regular Session · upper
Quick answers
Did OK SB 1030 pass?
No. OK SB 1030 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2025-03-05): Coauthored by Representative Deck
What is OK SB 1030 about?
OK SB 1030 is a bill in the 2026 Regular Session titled “Prescription drug pricing; prohibiting certain action. Effective date.”.
Who sponsors OK SB 1030?
Howard, Stinson are the primary sponsors of OK SB 1030.
- Introduced
- 2025-02-03
- Latest action
- 2025-03-05 — Coauthored by Representative Deck
- Bill type
- bill
- Last updated
- —
Sponsors
- Howardprimary
- Stinsonprimary
Committees
Not provided by source.
Action timeline
2025-02-03
First Reading
introduction,reading-1
2025-02-03
Authored by Senator Howard
2025-02-04
Second Reading referred to Business and Insurance
reading-2,referral-committee
2025-02-24
Coauthored by Representative Stinson (principal House author)
2025-03-05
Coauthored by Representative Deck
Versions
- IntroducedCompare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:30:20.811026Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=OK&identifier=SB 1030. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.